| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |